MétaCan
Menu
Back to cohort
Record W2074952360 · doi:10.1038/bjc.2012.451

Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer

2012· article· en· W2074952360 on OpenAlexaff
Victor Abkevich, Kirsten M. Timms, Bryan T. Hennessy, Jennifer Potter, Mark Carey, Lisa Meyer, Karen Smith‐McCune, Russell Broaddus, K.H. Lu, J Chen, Thuan Van Tran, Deniece R. Williams, Diana Iliev, Srikanth Jammulapati, Liesel M. FitzGerald, Thomas C. Krivak, Julie A. DeLoia, Alexander Gutin, Gordon B. Mills, J. S. Lanchbury

Bibliographic record

VenueBritish Journal of Cancer · 2012
Typearticle
Languageen
FieldMedicine
TopicPARP inhibition in cancer therapy
Canadian institutionsUniversity of British Columbia
FundersUniversity of California, San FranciscoUniversity of Texas MD Anderson Cancer CenterU.S. Public Health ServiceNational Cancer InstituteU.S. Department of Health and Human ServicesScience Foundation IrelandConquer Cancer FoundationNational Institutes of HealthStand Up To CancerEntertainment Industry Foundation
KeywordsLoss of heterozygosityHomologous recombinationOvarian cancerBiologyHomologous chromosomeCancer researchBreast cancerDNA repairBRCA2 ProteinGenome instabilityCancerGeneticsOncologyAlleleDNAGeneMedicineDNA damageMutationGermline mutation

Abstract

fetched live from OpenAlex

BACKGROUND: Defects in BRCA1, BRCA2, and other members of the homologous recombination pathway have potential therapeutic relevance when used to support agents that introduce or exploit double-stranded DNA breaks. This study examines the association between homologous recombination defects and genomic patterns of loss of heterozygosity (LOH). METHODS: Ovarian tumours from two independent data sets were characterised for defects in BRCA1, BRCA2, and RAD51C, and LOH profiles were generated. Publically available data were downloaded for a third independent data set. The same analyses were performed on 57 cancer cell lines. RESULTS: Loss of heterozygosity regions of intermediate size were observed more frequently in tumours with defective BRCA1 or BRCA2 (P=10(-11)). The homologous recombination deficiency (HRD) score was defined as the number of these regions observed in a tumour sample. The association between HRD score and BRCA deficiency was validated in two independent ovarian cancer data sets (P=10(-5) and 10(-29)), and identified breast and pancreatic cell lines with BRCA defects. CONCLUSION: The HRD score appears capable of detecting homologous recombination defects regardless of aetiology or mechanism. This score could facilitate the use of PARP inhibitors and platinum in breast, ovarian, and other cancers.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.003
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.006

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.003
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.017
GPT teacher head0.297
Teacher spread0.280 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations852
Published2012
Admission routes1
Has abstractyes

Explore more

Same venueBritish Journal of CancerSame topicPARP inhibition in cancer therapyFrench-language works237,207